Category: News - Psychedelic Alpha

Read more about the article Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH’s Dosing Model

Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH’s Dosing Model

Post published:July 1, 2025
Post category:Analysis News Pα+

Read more about the article Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Post published:July 1, 2025
Post category:Analysis News

Read more about the article Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout

Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout

Post published:June 28, 2025
Post category:Analysis News Pα+

Read more about the article Cautious Optimism, Lingering Questions: Researchers React to Compass’ Phase 3 Psilocybin Results

Cautious Optimism, Lingering Questions: Researchers React to Compass’ Phase 3 Psilocybin Results

Post published:June 25, 2025
Post category:Analysis News Pα+

Read more about the article Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle

Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle

Post published:June 23, 2025
Post category:Analysis News

Read more about the article Australia’s Largest Private Health Insurer Commits $10M to Fund MDMA Therapy for PTSD in First-of-its-Kind Program

Australia’s Largest Private Health Insurer Commits $10M to Fund MDMA Therapy for PTSD in First-of-its-Kind Program

Post published:June 18, 2025
Post category:Analysis News Pα+

Read more about the article Breaking: atai Moves to Acquire Beckley, If Phase 2b 5-MeO-DMT Data Delivers

Breaking: atai Moves to Acquire Beckley, If Phase 2b 5-MeO-DMT Data Delivers

Post published:June 2, 2025
Post category:Analysis News Pα+

Read more about the article Can a State Fast-Track a Psychedelic Breakthrough? Inside Texas’ Plan to Fund Ibogaine Trials

Can a State Fast-Track a Psychedelic Breakthrough? Inside Texas’ Plan to Fund Ibogaine Trials

Post published:May 28, 2025
Post category:Analysis News

Read more about the article Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive Disorder Study

Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive Disorder Study

Post published:May 27, 2025
Post category:Analysis News Pα+

Read more about the article Matt Zorn, the Government’s Former Adversary, Is Now Its Psychedelics Czar

Matt Zorn, the Government’s Former Adversary, Is Now Its Psychedelics Czar

Post published:May 24, 2025
Post category:Analysis News Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.